Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1

A novel probiotics-derived protein, P8, suppresses the growth of colorectal cancer (CRC). P8 can penetrate the cell membrane via endocytosis and cause cell cycle arrest in DLD-1 cells through down-regulation of CDK1/Cyclin B1. However, neither the protein involved in the endocytosis of P8 nor the cell cycle arrest targets of P8 are known. We identified two P8-interacting target proteins [importin subunit alpha-4 (KPNA3) and glycogen synthase kinase-3 beta (GSK3 & beta;)] using P8 as a bait in pull-down assays of DLD-1 cell lysates. Endocytosed P8 in the cytosol was found to bind specifically to GSK3 & beta;, preventing its inactivation by protein kinases AKT/CK1 & epsilon;/PKA. The subsequent activation of GSK3 & beta; led to strong phosphorylation (S-33,S-37/T-41) of & beta;-catenin, resulting in its subsequent degradation. P8 in the cytosol was also found to be translocated into the nucleus by KPNA3 and importin. In the nucleus, after its release, P8 binds directly to the intron regions of the GSK3 & beta; gene, leading to dysregulation of GSK3 & beta; transcription. GSK3 & beta; is a key protein kinase in Wnt signaling, which controls cell proliferation during CRC development. P8 can result in a cell cycle arrest morphology in CRC cells, even when they are in the Wnt ON signaling state.

Automated summary

A novel probiotics-derived protein, P8, can suppress the growth of colorectal cancer by causing cell cycle arrest in DLD-1 cells. P8 is able to penetrate the cell membrane via endocytosis and its interaction with importin subunit alpha-4 and glycogen synthase kinase-3 beta plays a crucial role in its mechanisms of action.